Heart (Implanted cardioverter defibrillator)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Implanted cardioverter defibrillator).php on line 2
Heart (Implanted cardioverter defibrillator)

LE WE PMID CA

Heart (Implanted cardioverter defibrillator)

1311

Herz (Implantierbarer Kardioverter Defibrillator)

Amiodarone

Azimilide

Cardiovascular risk

Electrical storm

Heart (Extrasystole ventricular and salve)

Heart (Implanted cardioverter defibrillator)

Heart (Inherited and congenital diseases in grown up patients)

Heart (Ventricular fibrillation)

Heart pacemaker (BASKET)

Heart pacemaker (biventricular)

Kidney (Chronic renal failure)

Long QT syndrome

Premedication and perioperative medicine

Resuscitation

Short QT syndrome

Sudden death (cardiogenic)

2003 1	Implantable devices for treating tachyarrhythmias. [12907492] BMJ 327(7410): 333-6 (2003)
2009 2	Expenditure and value for money: the challenge of implantable cardioverter defibrillators. [19276209] QJM 102(5): 349-56 (2009)
2003 3	Implantable defibrillator therapy. [12918543] Neth J Med 61(5 Suppl): 4-7 (2003)
2005 4	Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. [15983472] Anesthesiology 103(1): 186-98 (2005)
2007 5	Primary and secondary prevention of sudden cardiac death: who should get an ICD? [17934011] Heart 93(11): 1478-83 (2007)
2002 6	Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness. [11997415] Heart 87(5): 438-42 (2002)
2001 7	Implantable cardioverter-defibrillators. [11454851] Heart 86(2): 221-6 (2001)
2009 8	Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions. [19753515] Cardiol J 16(5): 391-3 (2009)
2004 9	Arrhythmia detection by dual-chamber implantable cardioverter defibrillators. A review of current algorithms. [15172650] Europace 6(4): 273-86 (2004)
2009 10	A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial. [19808459] Circ Arrhythm Electrophysiol 2(2): 146-53 (2009)
2008 11	Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease. [19808423] Circ Arrhythm Electrophysiol 1(4): 307-16; discussion 316 (2008)
2008 12	Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator. [19808422] Circ Arrhythm Electrophysiol 1(4): 298-306 (2008)
2006 13	A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. [16904046] Health Technol Assess 10(27): iii-iv, ix-xi, 1-164 (2006)
2005 14	The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review. [16153353] Health Technol Assess 9(36): 1-150, iii (2005)
2000 15	Implantable cardioverter defibrillators: arrhythmias. A rapid and systematic review. [11086270] Health Technol Assess 4(26): 1-69 (2000)
2007 16	Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. [17709759] Ann Intern Med 147(4): 251-62 (2007)
2003 17	Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. [12639076] Ann Intern Med 138(6): 445-52 (2003)
2000 18	The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death. [11103061] Ann Intern Med 133(11): 901-10 (2000)
1995 19	Implantable cardioverter-defibrillators: implications for the nonelectrophysiologist. [7717600] Ann Intern Med 122(10): 770-7 (1995)
2008 20	Results of the Predictors of Response to CRT (PROSPECT) trial. [18458170] Circulation 117(20): 2608-16 (2008)
2007 21	Highlighting the R in CRT. [17893284] Circulation 116(13): 1434-6 (2007)
2007 22	Sudden death prevention with implantable devices. [17664385] Circulation 116(5): 561-71 (2007)
2006 23	ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. [16935995] Circulation 114(10): e385-484 (2006)
2005 24	Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy. [15967863] Circulation 111(24): 3327-35 (2005)
2005 25	Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. [15900623] Circulation 111(19): 2537-49; discussion 2537-49 (2005)
2005 26	Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. [15897357] Circulation 111(19): 2537-49; discussion 2537-49 (2005)
2003 27	MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. [14557341] Circulation 108(15): 1779-83 (2003)
2002 28	ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). [12379588] Circulation 106(16): 2145-61 (2002)
1995 29	The proarrhythmic potential of implantable cardioverter-defibrillators. [7664453] Circulation 92(6): 1651-64 (1995)
1995 30	Clinical investigation of antiarrhythmic devices. A statement for healthcare professionals from a joint task force of the American Heart Association, the North American Society of Pacing and Electrophysiology, the American College of Cardiology, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology. [7895372] Circulation 91(7): 2097-109 (1995)
2007 31	Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review. [17227788] Eur Heart J 28(4): 469-77 (2007)
2006 32	ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. [16923744] Eur Heart J 27(17): 2099-140 (2006)
2003 33	MADIT-II and its implications. [12559932] Eur Heart J 24(1): 16-8 (2003)
2001 34	Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. [11428848] Eur Heart J 22(13): 1074-81 (2001)
2000 35	Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. [11102258] Eur Heart J 21(24): 2071-8 (2000)
1997 36	Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias. [9049512] Eur Heart J 18(1): 26-30 (1997)
2006 37	Primary prevention of sudden cardiac death. [17105896] Heart 92(12): 1873-8 (2006)
2004 38	The MADIT II and COMPANION studies: will they affect uptake of device treatment? [14966031] Heart 90(3): 243-5 (2004)
2004 39	Implantable cardioverter-defibrillator treatment and resynchronisation in heart failure. [14729810] Heart 90(2): 231-4 (2004)
2003 40	An audit of the implications of implementing NICE guidance on the use of implantable cardioverter-defibrillators. [12807860] Heart 89(7): 787-8 (2003)
2004 41	Indications for an implantable cardioverter defibrillator (ICD). [15206546] Intern Med 43(5): 360-7 (2004)
2008 42	American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. [18804749] J Am Coll Cardiol 52(14): 1179-99 (2008)
2008 43	Benefits of the implantable cardioverter-defibrillator. [18804737] J Am Coll Cardiol 52(14): 1122-7 (2008)
2008 44	A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. [18804736] J Am Coll Cardiol 52(14): 1111-21 (2008)
2008 45	Azimilide: another effort to prevent implantable cardioverter-defibrillator shocks and their sequelae why it is important and how it works. [18848142] J Am Coll Cardiol 52(13): 1084-5 (2008)
2008 46	ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. [18498951] J Am Coll Cardiol 51(21): e1-62 (2008)
2008 47	Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. [18206738] J Am Coll Cardiol 51(3): 288-96 (2008)
2006 48	Evaluation and management of patients after implantable cardioverter-defibrillator shock. [17179461] JAMA 296(23): 2839-47 (2006)
2004 49	Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. [15598919] JAMA 292(23): 2874-9 (2004)
2006 50	Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure. [16397075] Postgrad Med J 82(963): 16-23 (2006)
2009 51	Therapy with an implantable cardioverter defibrillator (ICD) in patients with coronary artery disease and dilated cardiomyopathy: benefits and disadvantages. [19950031] Swiss Med Wkly 139(45-46): 647-53 (2009)
2006 52	ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). [16949478] J Am Coll Cardiol 48(5): e247-346 (2006)
2006 53	Implantable cardioverter-defibrillator therapy in clinical practice. [16630984] J Am Coll Cardiol 47(8): 1507-17 (2006)
2004 54	Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. [15582314] J Am Coll Cardiol 44(11): 2166-72 (2004)
2004 55	Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators. [14715181] J Am Coll Cardiol 43(1): 44-6 (2004)
2003 56	Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. [12742300] J Am Coll Cardiol 41(9): 1573-82 (2003)
2008 57	Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. [18195289] CMAJ 178(2): 157-64 (2008)
2007 58	Implantable cardioverter defibrillators work--so why aren't we using them? [17606939] CMAJ 177(1): 49-51 (2007)
2010 59	Device sensing: sensors and algorithms for pacemakers and implantable cardioverter defibrillators. [20876446] Circulation 122(13): 1328-40 (2010)
2007 60	Patients with hemodynamically tolerated ventricular tachycardia require implantable cardioverter defibrillators. [17768303] Circulation 116(10): 1196-203 (2007)
2007 61	Transvenous implantable cardioverter-defibrillator leads: the weakest link. [17502585] Circulation 115(19): 2461-3 (2007)
2009 62	Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely. [19704090] Circulation 120(10): 825-7 (2009)
2008 63	American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. [18833586] Circulation 118(14): 1497-1518 (2008)
2009 64	Treating the long-QT syndrome in the era of implantable defibrillators. [19153279] Circulation 119(2): 204-6 (2009)
2004 65	Potential candidates for cardiac resynchronization therapy in Japanese patients with idiopathic dilated cardiomyopathy--a Niigata multicenter study of DCM--. [15564691] Circ J 68(12): 1104-9 (2004)
2009 66	Cardiac resynchronization therapy with and without implantable cardioverter-defibrillator. [19474508] Circ J 73 Suppl A(-): A29-35 (2009)
2006 67	Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children. [16952927] Eur Heart J 27(20): 2382-4 (2006)
2007 68	The cost of implantable defibrillators: perceptions and reality. [16887857] Eur Heart J 28(4): 392-7 (2007)
2007 69	The high cost of implantable defibrillators. [17032689] Eur Heart J 28(4): 388-91 (2007)
2008 70	What is the level of evidence for combined cardiac resynchronization and defibrillation therapy in heart failure? [18310672] Eur Heart J 29(5): 682-3; author reply 683-4 (2008)
2010 71	Subcutaneous ICD implantation. [20635570] Rev Port Cardiol 29(3): 451-7 (2010)
2010 72	Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry. [20400768] Europace 12(8): 1105-11 (2010)
2010 73	Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. [20974768] Europace 12(11): 1564-70 (2010)
2011 74	Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry. [21123220] Europace 13(4): 499-508 (2011)
2010 75	Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators. [20304841] Europace 12(5): 618-25 (2010)
2008 76	Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. [18708639] Europace 10(11): 1256-65 (2008)
2009 77	Implantable cardioverter defibrillators and their role in heart failure progression. [19357142] Europace 11(6): 710-5 (2009)
2009 78	Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. [19359333] Europace 11(6): 716-26 (2009)
2009 79	Inappropriate shocks or inappropriate programming? A review of Guidant's reconfirmation algorithm. [19443435] Europace 11(8): 1120-2 (2009)
2008 80	Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot. [18442962] Europace 10(8): 926-30 (2008)
2009 81	Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator. [19861397] Europace 11 Suppl 5(-): v87-92 (2009)
2009 82	Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis. [19812050] Europace 11(11): 1469-75 (2009)
2009 83	Implantable cardioverter defibrillator therapy for non-ischaemic cardiomyopathy. What is the role of programmed electrical stimulation? [19164361] Europace 11(3): 273-5 (2009)
2009 84	Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. [19136490] Europace 11(4): 465-75 (2009)
2009 85	Defibrillator implantation early after myocardial infarction. [19812399] N Engl J Med 361(15): 1427-36 (2009)
2011 86	Current pacemaker and defibrillator therapy. [21691561] Dtsch Arztebl Int 108(21): 372-9; quiz 380 (2011)
2008 87	Electrical storm: a new challenge in the age of implantable defibrillators. [18459465] Hellenic J Cardiol 49(2): 86-91 (2008)
2010 88	Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. [20730062] Vasc Health Risk Manag 6(-): 465-72 (2010)
2002 89	Implanted cardiac pacemakers and defibrillators in anaesthetic practice. [12066997] Br J Anaesth 88(5): 627-31 (2002)
2004 90	Pacemakers and defibrillators: anaesthetic implications. [15169736] Br J Anaesth 93(1): 95-104 (2004)
2011 91	The evaluation and management of electrical storm. [21494516] Tex Heart Inst J 38(2): 111-21 (2011)
2004 92	The evolution and revolution of the implantable cardioverter defibrillator. [15225105] Expert Rev Cardiovasc Ther 2(4): 461-4 (2004)
2008 93	Implantation of cardiac defibrillators for primary prevention: a pendulum too far? [18793106] Expert Rev Cardiovasc Ther 6(8): 1047-50 (2008)
2010 94	Implantable cardioverter-defibrillator therapy in congenital heart disease. [20021234] Expert Rev Med Devices 7(1): 1-3 (2010)
2011 95	Electrical storm: Incidence, Prognosis and Therapy. [21468247] Indian Pacing Electrophysiol J 11(2): 34-42 (2011)
2007 96	Defibrillation testing of the implantable cardioverter defibrillator: when, how, and by whom? [17684575] Indian Pacing Electrophysiol J 7(3): 166-75 (2007)
2007 97	Predictors of mortality amongst recipients of implantable cardioverter defibrillators for secondary prevention of cardiac arrest. [17957270] Indian Pacing Electrophysiol J 7(4): 218-24 (2007)
2010 98	Sudden cardiac death and implantable cardioverter-defibrillators. [21121520] Am Fam Physician 82(11): 1357-66 (2010)
PMC 99	Prognosis after implantation of cardioverter-defibrillators in Korean patients with Brugada syndrome. [24339285] Yonsei Med J 55(1):37-45 (2014)
PMC 100	Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy. [24493911] Indian Pacing Electrophysiol J 14(1):4-11 (2014)
PMC 101	QRS as a Risk Stratification Tool: Putting the Fragments Together. [24493910] Indian Pacing Electrophysiol J 14(1):1-3 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Implanted cardioverter defibrillator).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Implanted cardioverter defibrillator).php on line 92